China · Delayed Price · Currency is CNY Frontier Biotechnologies Statistics
Total Valuation
SHA:688221 has a market cap or net worth of CNY 6.21 billion. The enterprise value is 5.92 billion.
| Market Cap | 6.21B |
| Enterprise Value | 5.92B |
Important Dates
The last earnings date was Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688221 has 374.58 million shares outstanding. The number of shares has decreased by -0.62% in one year.
| Current Share Class | 374.58M |
| Shares Outstanding | 374.58M |
| Shares Change (YoY) | -0.62% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 14.85% |
| Owned by Institutions (%) | 16.60% |
| Float | 219.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 690.06 |
| PS Ratio | 16.43 |
| PB Ratio | 6.01 |
| P/TBV Ratio | 6.75 |
| P/FCF Ratio | 144.39 |
| P/OCF Ratio | 118.23 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 137.61 |
Financial Position
The company has a current ratio of 4.96, with a Debt / Equity ratio of 0.41.
| Current Ratio | 4.96 |
| Quick Ratio | 3.65 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 27.20 |
| Debt / FCF | 9.75 |
| Interest Coverage | -4.91 |
Financial Efficiency
Return on equity (ROE) is -2.10% and return on invested capital (ROIC) is -0.96%.
| Return on Equity (ROE) | -2.10% |
| Return on Assets (ROA) | -0.80% |
| Return on Invested Capital (ROIC) | -0.96% |
| Return on Capital Employed (ROCE) | -1.45% |
| Weighted Average Cost of Capital (WACC) | 8.60% |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | -69,334 |
| Employee Count | 314 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.37% in the last 52 weeks. The beta is 0.89, so SHA:688221's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +8.37% |
| 50-Day Moving Average | 20.94 |
| 200-Day Moving Average | 20.85 |
| Relative Strength Index (RSI) | 34.20 |
| Average Volume (20 Days) | 17,384,443 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688221 had revenue of CNY 378.04 million and -21.77 million in losses. Loss per share was -0.06.
| Revenue | 378.04M |
| Gross Profit | 283.37M |
| Operating Income | -21.84M |
| Pretax Income | -21.77M |
| Net Income | -21.77M |
| EBITDA | 14.74M |
| EBIT | -21.84M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 711.08 million in cash and 419.42 million in debt, with a net cash position of 291.66 million or 0.78 per share.
| Cash & Cash Equivalents | 711.08M |
| Total Debt | 419.42M |
| Net Cash | 291.66M |
| Net Cash Per Share | 0.78 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 2.78 |
| Working Capital | 952.75M |
Cash Flow
In the last 12 months, operating cash flow was 52.53 million and capital expenditures -9.52 million, giving a free cash flow of 43.01 million.
| Operating Cash Flow | 52.53M |
| Capital Expenditures | -9.52M |
| Depreciation & Amortization | 36.58M |
| Net Borrowing | 85.05M |
| Free Cash Flow | 43.01M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 74.96%, with operating and profit margins of -5.78% and -5.76%.
| Gross Margin | 74.96% |
| Operating Margin | -5.78% |
| Pretax Margin | -5.76% |
| Profit Margin | -5.76% |
| EBITDA Margin | 3.90% |
| EBIT Margin | -5.78% |
| FCF Margin | 11.38% |
Dividends & Yields
SHA:688221 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.62% |
| Shareholder Yield | 0.62% |
| Earnings Yield | -0.35% |
| FCF Yield | 0.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |